Skip to main content
SpringerLink
Log in

The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

An Erratum to this article was published on 18 August 2017

This article has been updated

Abstract

Background

Thrombocytosis has been reported in a variety of solid tumors, including certain gynecologic cancers such as endometrial, vulvar, and cervical cancers. The present study aims to determine the incidence of thrombocytosis in women with epithelial ovarian tumors and to evaluate its association with clinical and pathologic prognostic factors.

Material and methods

Between January 2001 and December 2006, 292 patients were diagnosed with epithelial ovarian tumors, and they underwent primary surgical treatment and subsequent platinum-based chemotherapy at the Gynecologic Oncology Department of the study center. The medical records of these patients were evaluated retrospectively.

Results

Of the 292 women with epithelial ovarian tumors undergoing primary surgical exploration, 124 (42.5%) had thrombocytosis, indicating platelet counts >400 × 109/l. Patients with thrombocytosis were found to have statistically higher levels of preoperative CA-125 levels, more advanced stage disease, higher grade tumors, and shorter periods of survival. Thrombocytosis is a significant negative prognostic factor for survival in patients with epithelial ovarian tumors.

Conclusions

Thrombocytosis is frequently detected in preoperative evaluation of women diagnosed with epithelial ovarian tumors. The data obtained by the previous and present studies suggest that thrombocytosis is associated with factors reflecting a more aggressive tumor biology, and predicting poor survival in women with epithelial ovarian tumors. However, these data are limited by the retrospective nature of the studies and do not confirm a casual relationship between thrombocytosis and tumor behavior. Molecular studies investigating the expression of platelet secretory factors are required to clarify the differences among data provided by the literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Change history

  • 18 August 2017

    An erratum to this article has been published.

References

  1. Amoletti JP, Albo D, Granick MS, Solomon MP, Castiglioni A, Rothman VL et al (1995) Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 76:998–1005

    Article  Google Scholar 

  2. Benoy I, Salgado R, Colpaert C, Weytjens R (2002) Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer 2:311–315

    Article  CAS  PubMed  Google Scholar 

  3. Chalas E, Welshinger M, Engellener W, Chumas J, Barbieri R, Mann WJ (1992) The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol 166:974–977

    Article  CAS  PubMed  Google Scholar 

  4. Constantini V, Zacharski LR, Moritz TE, Edwards RL (1990) The platelet count in carcinoma of the lung and colon. Thromb Haemost 64:501–505

    Google Scholar 

  5. Dabrow MB, Francesco MR, McBrearty FX, Caradonna S (1998) The effect of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecol Oncol 71:29–37

    Article  CAS  PubMed  Google Scholar 

  6. Friebe Z, Watrowski R, Bembnista M, Rokowska A, Wlosiinska J (2005) Correlation between platelet count and CA–125 in ovarian cancer. Ginekol Pol 76(3):187–194

    PubMed  Google Scholar 

  7. Gastl G, Plante M, Finstad CL, Wong GY, Federici MG, Bander NH et al (1993) High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 83:433–441

    Article  CAS  PubMed  Google Scholar 

  8. Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C et al (2000) Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 21:309–314

    Article  CAS  PubMed  Google Scholar 

  9. Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB (2000) The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 78:137–142

    Article  CAS  PubMed  Google Scholar 

  10. Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9:287–291

    Article  PubMed  Google Scholar 

  11. Kerpsack JT, Finan MA (2000) Thrombocytosis as a predictor of malignancy in women with a pelvic mass. J Reprod Med 45:929–932

    CAS  PubMed  Google Scholar 

  12. Levin J, Conley CL (1964) Thrombocytosis associated with malignant disease. Arch Int Med 114:497–500

    Article  CAS  Google Scholar 

  13. Li AJ, Madden CM, Cass I, Leuchter RS, Lagasse LD (2004) The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 92:211–214

    Article  PubMed  Google Scholar 

  14. Menczer J, Schejter E, Geva D, Ginath S (1998) Ovarian carcinoma associated thrombocytosis: correlation with prognostic factors and with survival. Eur J Gynaecol Oncol 12:82–84

    Google Scholar 

  15. O’Keefe SC, Marshall FF, Issa MM, Harmon MP, Petros JA (2002) Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 168:1378–1380

    Article  PubMed  Google Scholar 

  16. Pedersen LM, Milman N (2003) Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep 10:213–216

    PubMed  Google Scholar 

  17. Qian X, Tuszynski GP (1996) Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc Soc Exp Biol Med 212:199–207

    Article  CAS  PubMed  Google Scholar 

  18. Scholz HS, Petru E, Gucer F, Haas J (2000) Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res 20:3983–3985

    CAS  PubMed  Google Scholar 

  19. Schwarz RE, Keny H (2001) Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma. Hepatogastroenterology 48:1493–1498

    CAS  PubMed  Google Scholar 

  20. Soonthornthum T, Suraseraneewong V, Kengsakol K, Wijaithum K (2007) Thrombocytosis in advanced epithelial ovarian cancer. J Med Assoc Thai 90(8):1495–1500

    PubMed  Google Scholar 

  21. Tamussino KF, Gucer F, Reich O, Moser F, Petru E (2001) Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer 11:236–240

    Article  CAS  PubMed  Google Scholar 

  22. Zeimet AG, Marth C, Muller-Holzmer E, Daxenbichler G (1994) Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 170:549–554

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecologic Oncology, Dr Zekai Tahir Burak Women Health Education and Research Hospital, Ankara, Turkey

    Tayfun Gungor, Mine Kanat-Pektas, Ayhan Sucak & Leyla Mollamahmutoglu

  2. Ertugrul Gazi Mah, Kutlugun Sok. No. 37/14, 06590, Iccebeci, Ankara, Turkey

    Mine Kanat-Pektas

Authors
  1. Tayfun Gungor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mine Kanat-Pektas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ayhan Sucak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leyla Mollamahmutoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mine Kanat-Pektas.

Additional information

An erratum to this article is available at https://doi.org/10.1007/s00404-017-4483-9.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gungor, T., Kanat-Pektas, M., Sucak, A. et al. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet 279, 53–56 (2009). https://doi.org/10.1007/s00404-008-0673-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-008-0673-9

Keywords

Search

Navigation